Mechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It
about
Long non-coding RNAs in anti-cancer drug resistanceThe Under-Appreciated Promiscuity of the Epidermal Growth Factor Receptor FamilyIn vivo models in breast cancer research: progress, challenges and future directions.HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss.Expression of T-Lymphocyte Markers in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.Entinostat for the treatment of breast cancer.DeBouganin Diabody Fusion Protein Overcomes Drug Resistance to ADCs Comprised of Anti-Microtubule Agents.HER2-Orientated Therapy in Early and Metastatic Breast Cancer.EGFR Family Members' Regulation of Autophagy Is at a Crossroads of Cell Survival and Death in Cancer.Identification of an HSP90 modulated multi-step process for ERBB2 degradation in breast cancer cells.Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers.ESE-1 Knockdown Attenuates Growth in Trastuzumab-resistant HER2+ Breast Cancer Cells.Progesterone impairs Herceptin effect on breast cancer cells.Targeting HER2 in Nuclear Medicine for Imaging and Therapy.Rapid symptomatic relief of HER2-positive gastric cancer leptomeningeal carcinomatosis with lapatinib, trastuzumab and capecitabine: a case report.Astatine-211 labeled anti-HER2 5F7 single domain antibody fragment conjugates: radiolabeling and preliminary evaluation.Virus-like particle display of HER2 induces potent anti-cancer responses.LMO4 mediates trastuzumab resistance in HER2 positive breast cancer cells.Metastatic Dermatosis in Breast Carcinoma on Adjuvant Trastuzumab: Is Skin a Sanctuary Site in Human Epidermal Growth Factor Receptor-2-Amplified Disease?Relationship between gene status and selected potential biological features related to trastuzumab resistance and its influence on survival of breast cancer patients undergoing trastuzumab adjuvant treatment
P2860
Q28072366-B31B3B3F-A56D-4A07-81DF-370060484146Q28073335-197E77B8-EFBE-4095-92C6-6A9F6AD9BDB5Q33588117-03178676-7509-4B6F-91D0-C2FF8146832CQ33626569-E5F87A4A-D1B1-4691-A84C-10E54B899D55Q37547952-96EB946A-5184-4459-8ADE-359003C70E4DQ38674317-0EB3BE86-3FF8-4D18-A67F-0254C450CB85Q38725127-762D53EB-5B77-4A6C-9F3D-533871EDE9AFQ39147155-D0046F43-D964-4E1F-A568-920D94B1AFE9Q39198504-9CC37382-0797-4B2E-8ED1-AA432A3B8D1BQ41773399-B10076F9-B9EC-49DB-AA70-2FEC9ECBA8A3Q42281218-5DF29FFE-9D4F-4428-B98F-78063076BC8DQ47350657-66706F25-4049-4911-B8E8-C7D546FC5F8CQ49639590-DBB94B70-3BAA-4C20-864A-BF4270C4EE9DQ49700421-4F41F5E7-BCFC-49D5-B360-F040E6FBF8EFQ49796158-ECFC951C-822D-4F8F-AFFC-32EE0D52D1F7Q50068024-CE73ABE1-FBCC-4CEE-960B-2A5B3C54E869Q52699878-BA9FBCBB-69AE-4ACE-9761-A943866C6E79Q53686361-4C1E8F8B-869E-4B35-B3F4-7D11487714DBQ58776202-6C16DC88-4A17-4B7C-BB09-CF2318614812Q58801931-82C8C3EF-F5DA-4192-9343-19F476E902C8
P2860
Mechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Mechanisms Behind the Resistan ...... and Strategies to Overcome It
@ast
Mechanisms Behind the Resistan ...... and Strategies to Overcome It
@en
Mechanisms Behind the Resistan ...... and Strategies to Overcome It
@nl
type
label
Mechanisms Behind the Resistan ...... and Strategies to Overcome It
@ast
Mechanisms Behind the Resistan ...... and Strategies to Overcome It
@en
Mechanisms Behind the Resistan ...... and Strategies to Overcome It
@nl
prefLabel
Mechanisms Behind the Resistan ...... and Strategies to Overcome It
@ast
Mechanisms Behind the Resistan ...... and Strategies to Overcome It
@en
Mechanisms Behind the Resistan ...... and Strategies to Overcome It
@nl
P2093
P2860
P3181
P356
P1476
Mechanisms Behind the Resistan ...... and Strategies to Overcome It
@en
P2093
Isabel Palacio-Vázquez
Luisa Sánchez-Lorenzo
María Luque-Cabal
Paula García-Teijido
Yolanda Fernández-Pérez
P2860
P3181
P356
10.4137/CMO.S34537
P407
P433
P577
2016-01-01T00:00:00Z